KH617

· Sichuan Honghe Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for KH617, covering 2024-11-27 to 2025-08-22. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Clinical Trial of KH617 [Phase 2]